-
UPDATE: Bank of America Initiates Coverage on NPS Pharmaceuticals as Gattex and Natpara Could Provide Meaningful Annuities
Thursday, October 3, 2013 - 10:17am | 121Read More...In a report published Thursday, Bank of America analyst Tazeen Ahmad initiated coverage on NPS Pharmaceuticals (NASDAQ: NPSP) with a Buy rating and $46.00 price target. In the report, Bank of America noted, “We are initiating coverage of NPS Pharmaceuticals (NPSP) with a Buy rating and PO of $46....
